Portal de Periódicos da CAPES

THE USEFULNESS OF 1,25‐DIHYDROXY‐VITAMIN D 3 (1,25(OH) 2 vit D 3 ) IN THE TREATMENT OF IDIOPATHIC MYELOFIBROSIS

1986; Wiley; Volume: 62; Issue: 2 Linguagem: Inglês

10.1111/j.1365-2141.1986.tb02946.x

1365-2141

Carlos Richard, Francisco Mazorra, A Iriondo, Е Б Мазо, C. Belló, Ana Castro Zubizarreta,

Chronic Myeloid Leukemia Treatments

British Journal of HaematologyVolume 62, Issue 2 p. 399-400 Free Access THE USEFULNESS OF 1,25-DIHYDROXY-VITAMIN D3 (1,25(OH)2 vit D3) IN THE TREATMENT OF IDIOPATHIC MYELOFIBROSIS C. Richard, C. Richard Hematology Department, Marques de Valdecinal National Hospital, Santander, SpainSearch for more papers by this authorF. Mazorra, F. Mazorra Pathology Department, Marques de Valdecinal National Hospital, Santander, SpainSearch for more papers by this authorA. Iriondo, A. Iriondo Hematology Department, Marques de Valdecinal National Hospital, Santander, SpainSearch for more papers by this authorE. Mazo, E. Mazo Hematology Department, Marques de Valdecinal National Hospital, Santander, SpainSearch for more papers by this authorC. Bello, C. Bello Hematology Department, Marques de Valdecinal National Hospital, Santander, SpainSearch for more papers by this authorA. Zubizarreta, A. Zubizarreta Hematology Department, Marques de Valdecinal National Hospital, Santander, SpainSearch for more papers by this author C. Richard, C. Richard Hematology Department, Marques de Valdecinal National Hospital, Santander, SpainSearch for more papers by this authorF. Mazorra, F. Mazorra Pathology Department, Marques de Valdecinal National Hospital, Santander, SpainSearch for more papers by this authorA. Iriondo, A. Iriondo Hematology Department, Marques de Valdecinal National Hospital, Santander, SpainSearch for more papers by this authorE. Mazo, E. Mazo Hematology Department, Marques de Valdecinal National Hospital, Santander, SpainSearch for more papers by this authorC. Bello, C. Bello Hematology Department, Marques de Valdecinal National Hospital, Santander, SpainSearch for more papers by this authorA. Zubizarreta, A. Zubizarreta Hematology Department, Marques de Valdecinal National Hospital, Santander, SpainSearch for more papers by this author First published: February 1986 https://doi.org/10.1111/j.1365-2141.1986.tb02946.xCitations: 15AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES Arlet, Ph., Nicodeme, R., Adoue, D., Larregain-Fournier, D., Delsol, G. & Le Tallec, Y. (1984) Clinical evidence for 1,25-hydroxycholecalciferol action in myelofibrosis. Lancet, I, 1013–1014. Koeffler, Ph. (1983) Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood, 62, 709–721. Mccarthy, D.M. (1985) Fibrosis of the bone marrow: content and causes. British Journal of Haematology, 59, 1–7. Mccarthy, D.M., Hibbin, J.A. & Holmand, J.M. (1984) A role for 1,25-hydroxyvitamin D3 in control of bone marrow collagen deposition Lancet, i, 78–80. Citing Literature Volume62, Issue2February 1986Pages 399-400 ReferencesRelatedInformation